Electroactive Polymer Actuators for Medical Applications (Printed Electronics Europe 2013)

• Electroactive polymers (EAPs) are intelligent materials uniquely positioned to provide biocompatible actuation at the microscale.

• Microactuated medical devices may enable better therapeutic outcomes.

• Enhancing reliability of EAPs performance will lead to their mainstream adoption in medical applications and beyond.

• SynapTech Discovery™, an EAP actuation testing platform, is on the horizon and is the first step towards EAP popularization.

Eugene Daneshvar has expertise in electroactive polymers, microfabrication, and neural engineering. He holds degrees in Electrical and Biomedical Engineering from the University of Michigan. His doctorate is focused on the characterization of electroactive polymers under physiological conditions. Eugene has an interest in intellectual property and has multiple patents pending. He is a member of IEEE, SPIE, Society for Neuroscience, and Biomedical Engineering Society.

SynapTech is dedicated to the development, manufacture and distribution of novel electroactive polymer-enabled products. SynapTech Discovery™ is our first product and a proprietary diagnostic platform that reduces the time, cost and complexity of testing electroactive polymers while improving the quality and accuracy of the results.

 

SynapTech holds intellectual property rights for multiple patents pending and is available for partnerships and investment.